|
Vaidyanathan, G; Zalutsky, M R; DeGrado, T R (1998) Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine. Bioconjug Chem 9:758-64
|
|
DeGrado, T R; Zalutsky, M R; Coleman, R E et al. (1998) Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart. Nucl Med Biol 25:59-64
|
|
Vaidyanathan, G; Zhao, X G; Strickland, D K et al. (1997) No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog. J Nucl Med 38:330-4
|
|
Vaidyanathan, G; Affleck, D J; Zalutsky, M R (1996) No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine. Bioconjug Chem 7:102-7
|
|
Vaidyanathan, G; Friedman, H S; Keir, S T et al. (1996) Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model. Nucl Med Biol 23:851-6
|
|
Vaidyanathan, G; Friedman, H S; Keir, S T et al. (1996) Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity. Br J Cancer 73:1171-7
|
|
Vaidyanathan, G; Zalutsky, M R (1996) Targeted therapy using alpha emitters. Phys Med Biol 41:1915-31
|
|
Degrado, T R; Zalutsky, M R; Vaidyanathan, G (1995) Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol 22:1-12
|
|
Strickland, D K; Vaidyanathan, G; Friedman, H S et al. (1995) Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines. J Neurooncol 25:9-17
|
|
Vaidyanathan, G; Affleck, D J; Zalutsky, M R (1995) Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. J Nucl Med 36:644-50
|
Showing the most recent 10 out of 14 publications
